LexDanaLexDanabeta
Inventor

WILLIAM J. POLVINO

Inventor
US

Overview

3→
Patents
2021–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
A61KPreparations for medical, dental or toiletry purposes33%
C07DHeterocyclic compounds17%
PatentTitleYear
11,964,960Pyridinone- and pyridazinone-based compounds and uses thereof202411,957,666Regimen for suppressing organ rejection202411,141,408Regimen for suppressing organ rejection2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2024Patents assigned to VELOXIS PHARMACEUTICALS INC (2)· patent assignee history
2021Patents assigned to VELOXIS PHARMACEUTICALS AS (1)· patent assignee history
2021–2024Based in US· patent location history
2024Patents assigned to TRI INST THERAPEUTICS DISCOVERY INST (1)· patent assignee history
2024Patents assigned to UNIV CORNELL (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
VELOXIS PHARMACEUTICALS INC22021–2024
TRI INST THERAPEUTICS DISCOVERY INST12024
UNIV CORNELL12024
VELOXIS PHARMACEUTICALS AS12021
Locations
LocationPatentsSpan
US32021–2024